Medicare Enrolled
Dr. William Desimone, M.D.
Family Medicine · Katy, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Desimone from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Desimone? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Desimone
Dr. William Desimone is a family medicine in Katy, TX, with 11 years in practice. Based on federal Medicare data, Dr. Desimone performed 3,008 Medicare services across 1,010 unique beneficiaries.
Between the years covered by Open Payments, Dr. Desimone received a total of $13,487 from 67 pharmaceutical and/or device companies across 604 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Desimone is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice▲ Top 8% volume in TX$ $13,487 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,008
Medicare services
Top 8% in TX for family medicine
1,010
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~273 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Extended-release steroid injection (Zilretta) | 960 | $13 | $25 |
| Office visit, established patient (30-39 min) | 750 | $87 | $185 |
| Chronic care management, first 20 min/month | 192 | $50 | $80 |
| Betamethasone steroid injection | 123 | $5 | $10 |
| Remote patient monitoring device, 30 days | 116 | $41 | $75 |
| Remote patient monitoring management, 20 min/month | 109 | $39 | $75 |
| Flu vaccine administration | 96 | $31 | $35 |
| Flu vaccine, high-dose | 93 | $71 | $90 |
| Annual wellness visit, follow-up | 91 | $133 | $200 |
| Joint injection, major joint | 61 | $54 | $155 |
| Hospital follow-up visit, moderate complexity | 57 | $64 | $120 |
| Telephone medical discussion with physician, 21-30 minutes | 51 | $75 | $175 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 44 | $170 | $203 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 38 | $15 | $30 |
| Office visit, established patient, complex (40-54 min) | 33 | $136 | $249 |
| Detection test by immunoassay technique for influenza virus | 26 | $13 | $30 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 25 | $39 | $110 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 21 | $73 | $200 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 21 | $273 | $314 |
| Pneumonia vaccine administration | 20 | $31 | $35 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 20 | $32 | $80 |
| New patient office visit (45-59 min) | 17 | $87 | $244 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 17 | $16 | $40 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 14 | $32 | $75 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 13 | $170 | $209 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,487
Total received (2018-2024)
Avg $1,927/year across 7 years
Top 3% in TX for family medicine
67
Companies
604
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,487 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,796
2023$2,497
2022$1,372
2021$2,109
2020$1,364
2019$2,514
2018$835
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$2,211
AstraZeneca Pharmaceuticals LP
$2,064
Abbott Laboratories
$1,048
Lilly USA, LLC
$883
Boehringer Ingelheim Pharmaceuticals, Inc.
$872
AbbVie Inc.
$755
Amgen Inc.
$734
Amarin Pharma Inc.
$720
Regeneron Healthcare Solutions, Inc.
$366
GlaxoSmithKline, LLC.
$344
Kowa Pharmaceuticals America, Inc.
$269
Flexion Therapeutics, Inc.
$262
Corcept Therapeutics
$228
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$218
PFIZER INC.
$218
Phathom Pharmaceuticals, Inc.
$197
IDORSIA PHARMACEUTICALS US INC
$165
Horizon Therapeutics plc
$135
Novartis Pharmaceuticals Corporation
$121
SANOFI-AVENTIS U.S. LLC
$115
SI-BONE, Inc.
$110
DePuy Synthes Sales Inc.
$106
Inspire Medical Systems, Inc.
$98
Esperion Therapeutics, Inc.
$75
Pacira Pharmaceuticals Incorporated
$64
Allergan, Inc.
$58
Sumitomo Pharma America, Inc.
$56
ABBVIE INC.
$54
Mylan Specialty L.P.
$54
Janssen Pharmaceuticals, Inc
$51
Sunovion Pharmaceuticals Inc.
$50
SANOFI PASTEUR INC.
$41
Astellas Pharma US Inc
$40
Althera Pharmaceuticals LLC
$39
Inogen, Inc.
$33
MAYNE PHARMA COMMERCIAL LLC
$33
Mallinckrodt Hospital Products Inc.
$32
Seqirus USA Inc
$27
Bayer Healthcare Pharmaceuticals Inc.
$27
Neuronetics, Inc.
$26
Edwards Lifesciences Corporation
$26
Nevro Corp.
$25
Otsuka America Pharmaceutical, Inc.
$24
GENZYME CORPORATION
$24
Bayer HealthCare Pharmaceuticals Inc.
$23
E.R. Squibb & Sons, L.L.C.
$22
Dynavax Technologies Corporation
$22
Melinta Therapeutics, LLC
$20
Lupin Inc.
$20
Biohaven Pharmaceutical Holding Company Ltd.
$20
Radius Health, Inc.
$20
Exact Sciences Corporation
$19
Eisai Inc.
$19
Meditrina
$19
Hologic Sales and Service, LLC
$18
Ferring Pharmaceuticals Inc.
$18
Intercept Pharmaceuticals, Inc.
$15
MAYNE PHARMA INC.
$15
AIMMUNE THERAPEUTICS, INC.
$14
Biohaven Pharmaceuticals, Inc.
$14
Inari Medical, Inc.
$13
Merck Sharp & Dohme LLC
$13
Janssen Biotech, Inc.
$13
Shionogi Inc
$13
PhotoniCare Inc
$13
Sanofi Pasteur Inc.
$12
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 39.5% of total payments
Associated products mentioned in payments ›
ACTHAR · AIRSUPRA · AREXVY · Aimovig · Aveta · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · BYDUREON · CHANTIX · Cologuard Collection Kit · DUPIXENT · Dayvigo · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMGALITY · ENTRESTO · EUFLEXXA · EVENITY · Exparel · FARXIGA · FLOWTRIEVER CATHETER · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUCELVAX QUADRIVALENT · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fluad Quadrivalent · FreeStyle Libre · GARDASIL · GARDASIL 9 · GEMTESA · GLYXAMBI · Heplisav-B · INSPIRE · InogenOne · JARDIANCE · KRYSTEXXA · Kerendia · Kimyrsa · Korlym · Kyleena · LEQVIO · LINZESS · LIVALO · LONHALA MAGNAIR · Livalo · MONOVISC · MOUNJARO · MYRBETRIQ · NEUROSTAR TMS THERAPY · NEXLETOL · NURTEC ODT · Omnia · Otezla · OtoSight Middle Ear Scope · Ozempic · PENNSAID · PREVNAR 13 · PREVNAR 20 · PROCLAIM · PRODIGY · QULIPTA · QUVIVIQ · REMICADE · REXULTI · RYBELSUS · Repatha · Roszet · Rybelsus · S · SEGLENTIS · SHINGRIX · SOLIQUA 100/33 · SOLOSEC · SPIRIVA RESPIMAT · SYMBICORT · SYNJARDY · Saxenda · Symproic · THINPREP 2000 PROCESSOR · TOUJEO · TRELEGY ELLIPTA · TRULICITY · Tresiba · Tymlos · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Wegovy · XARELTO · XIFAXAN · YUPELRI · Yupelri · ZENPEP · ZEPBOUND · ZORYVE · Zilretta · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for family medicine in TX.
Equivalent to $448 per 100 Medicare services performed
Geographic Context
Family Medicines within 10 mi
1,340
Per 100K population
28.2
County median income
$73,104
Nearest hospital
OCEANS BEHAVIORAL HOSPITAL OF KATY
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Desimone is a clinical cardiology specialist, with above-average Medicare volume (top 8% in TX), and high industry engagement (low-engagement, top 3%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Desimone experienced with extended-release steroid injection (zilretta)?
Based on Medicare claims data, Dr. Desimone performed 960 extended-release steroid injection (zilretta) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Desimone receive payments from pharmaceutical companies?
Yes. Dr. Desimone received a total of $13,487 from 67 companies across 604 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Desimone's costs compare to other family medicines in Katy?
Dr. Desimone's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Desimone) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in Katy
Browse family medicines in Katy ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in TX
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in TX
Which TX family medicines receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology